IBDEI1VO ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33039,1,3,0)
 ;;=3^Alcoholic Hepatic Failure w/o Coma
 ;;^UTILITY(U,$J,358.3,33039,1,4,0)
 ;;=4^K70.40
 ;;^UTILITY(U,$J,358.3,33039,2)
 ;;=^5008790
 ;;^UTILITY(U,$J,358.3,33040,0)
 ;;=K70.41^^182^1995^5
 ;;^UTILITY(U,$J,358.3,33040,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33040,1,3,0)
 ;;=3^Alcoholic Hepatic Failure w/ Coma
 ;;^UTILITY(U,$J,358.3,33040,1,4,0)
 ;;=4^K70.41
 ;;^UTILITY(U,$J,358.3,33040,2)
 ;;=^5008791
 ;;^UTILITY(U,$J,358.3,33041,0)
 ;;=K73.0^^182^1995^15
 ;;^UTILITY(U,$J,358.3,33041,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33041,1,3,0)
 ;;=3^Hepatitis, Chronic Persistent NEC
 ;;^UTILITY(U,$J,358.3,33041,1,4,0)
 ;;=4^K73.0
 ;;^UTILITY(U,$J,358.3,33041,2)
 ;;=^5008811
 ;;^UTILITY(U,$J,358.3,33042,0)
 ;;=K74.0^^182^1995^14
 ;;^UTILITY(U,$J,358.3,33042,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33042,1,3,0)
 ;;=3^Hepatic Fibrosis
 ;;^UTILITY(U,$J,358.3,33042,1,4,0)
 ;;=4^K74.0
 ;;^UTILITY(U,$J,358.3,33042,2)
 ;;=^5008816
 ;;^UTILITY(U,$J,358.3,33043,0)
 ;;=K74.69^^182^1995^10
 ;;^UTILITY(U,$J,358.3,33043,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33043,1,3,0)
 ;;=3^Cirrhosis of Liver,Oth
 ;;^UTILITY(U,$J,358.3,33043,1,4,0)
 ;;=4^K74.69
 ;;^UTILITY(U,$J,358.3,33043,2)
 ;;=^5008823
 ;;^UTILITY(U,$J,358.3,33044,0)
 ;;=K74.60^^182^1995^11
 ;;^UTILITY(U,$J,358.3,33044,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33044,1,3,0)
 ;;=3^Cirrhosis of Liver,Unspec
 ;;^UTILITY(U,$J,358.3,33044,1,4,0)
 ;;=4^K74.60
 ;;^UTILITY(U,$J,358.3,33044,2)
 ;;=^5008822
 ;;^UTILITY(U,$J,358.3,33045,0)
 ;;=K76.0^^182^1995^12
 ;;^UTILITY(U,$J,358.3,33045,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33045,1,3,0)
 ;;=3^Fatty Liver NEC
 ;;^UTILITY(U,$J,358.3,33045,1,4,0)
 ;;=4^K76.0
 ;;^UTILITY(U,$J,358.3,33045,2)
 ;;=^5008831
 ;;^UTILITY(U,$J,358.3,33046,0)
 ;;=K76.89^^182^1995^18
 ;;^UTILITY(U,$J,358.3,33046,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33046,1,3,0)
 ;;=3^Liver Disease NEC
 ;;^UTILITY(U,$J,358.3,33046,1,4,0)
 ;;=4^K76.89
 ;;^UTILITY(U,$J,358.3,33046,2)
 ;;=^5008835
 ;;^UTILITY(U,$J,358.3,33047,0)
 ;;=K71.6^^182^1995^31
 ;;^UTILITY(U,$J,358.3,33047,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33047,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatitis NEC
 ;;^UTILITY(U,$J,358.3,33047,1,4,0)
 ;;=4^K71.6
 ;;^UTILITY(U,$J,358.3,33047,2)
 ;;=^5008801
 ;;^UTILITY(U,$J,358.3,33048,0)
 ;;=K75.9^^182^1995^17
 ;;^UTILITY(U,$J,358.3,33048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33048,1,3,0)
 ;;=3^Inflammatory Liver Disease,Unspec
 ;;^UTILITY(U,$J,358.3,33048,1,4,0)
 ;;=4^K75.9
 ;;^UTILITY(U,$J,358.3,33048,2)
 ;;=^5008830
 ;;^UTILITY(U,$J,358.3,33049,0)
 ;;=K71.0^^182^1995^23
 ;;^UTILITY(U,$J,358.3,33049,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33049,1,3,0)
 ;;=3^Toxic Liver Disease w/ Cholestasis
 ;;^UTILITY(U,$J,358.3,33049,1,4,0)
 ;;=4^K71.0
 ;;^UTILITY(U,$J,358.3,33049,2)
 ;;=^5008793
 ;;^UTILITY(U,$J,358.3,33050,0)
 ;;=K71.10^^182^1995^29
 ;;^UTILITY(U,$J,358.3,33050,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33050,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/o Coma
 ;;^UTILITY(U,$J,358.3,33050,1,4,0)
 ;;=4^K71.10
 ;;^UTILITY(U,$J,358.3,33050,2)
 ;;=^5008794
 ;;^UTILITY(U,$J,358.3,33051,0)
 ;;=K71.11^^182^1995^30
 ;;^UTILITY(U,$J,358.3,33051,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33051,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/ Coma
 ;;^UTILITY(U,$J,358.3,33051,1,4,0)
 ;;=4^K71.11
 ;;^UTILITY(U,$J,358.3,33051,2)
 ;;=^5008795
 ;;^UTILITY(U,$J,358.3,33052,0)
 ;;=K71.2^^182^1995^22
 ;;^UTILITY(U,$J,358.3,33052,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33052,1,3,0)
 ;;=3^Toxic Liver Disease w/ Acute Hepatitis
 ;;
 ;;$END ROU IBDEI1VO
